MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

19 May 2025 Evaluate
The sales figure stood at Rs. 563.04 millions for the March 2025 quarter. The mentioned figure indicates a growth of about 43.87% as compared to Rs. 391.36 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 212.27% to Rs. 113.73  millions  from Rs. 36.42 millions in previous same quarter.OP of the company witnessed a marginal growth to 162.30 millions from 61.13 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 563.04 391.36 43.87 1815.87 1315.99 37.99 1815.87 1315.99 37.99
Other Income 23.25 8.96 159.49 137.15 61.89 121.60 137.15 61.89 121.60
PBIDT 162.30 61.13 165.50 445.53 265.06 68.09 445.53 265.06 68.09
Interest 7.21 4.45 62.02 21.26 19.08 11.43 21.26 19.08 11.43
PBDT 155.09 56.68 173.62 424.27 245.98 72.48 424.27 245.98 72.48
Depreciation 5.11 4.10 24.63 17.37 12.44 39.63 17.37 12.44 39.63
PBT 149.98 52.58 185.24 406.90 233.54 74.23 406.90 233.54 74.23
TAX 36.25 16.16 124.32 95.33 57.79 64.96 95.33 57.79 64.96
Deferred Tax 0.66 3.01 -78.07 -3.17 -5.86 -45.90 -3.17 -5.86 -45.90
PAT 113.73 36.42 212.27 311.57 175.75 77.28 311.57 175.75 77.28
Equity 160.82 160.82 0.00 160.82 160.82 0.00 160.82 160.82 0.00
PBIDTM(%) 28.83 15.62 84.54 24.54 20.14 21.82 24.54 20.14 21.82
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..